Literature DB >> 62590

Alpha-globulins in the surveillance of colorectal cancer.

E H Cooper, R Turner, A Geekie, A M Neville, J C Goligher, N G Graham, G R Giles, R Hall, W A Macadam.   

Abstract

The alpha1 and alpha2-globulins have been studied at various stages in the evolution of colo-rectal cancer. The alph2 was elevated in some primary tumours and rose in metastatic cancer especially when it involved the liver. Some apparently tumour free patients had an unexplained elevation of alph2-globulins. The macroglobulins were not a major constituent of the raised alpha2-globulins. Haptoglobulin levels were found to be a useful indicator of tumour activity, when their level was raised in metastatic cancer it was usually with an antecedent or coincidental rise of plasma CEA. Primary tumours may cause a high haptoglobin response without an elevation of CEA.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 62590

Source DB:  PubMed          Journal:  Biomedicine        ISSN: 0300-0893


  6 in total

1.  Biochemical profiles in tumour monitoring and their analysis.

Authors:  E H Cooper; T E Kenny
Journal:  Proc R Soc Med       Date:  1977-12

2.  Evaluation of biochemical markers in breast cancer.

Authors:  R C Coombes; T J Powles; A M Neville
Journal:  Proc R Soc Med       Date:  1977-12

3.  Immunosuppressive effect of acute-phase reactant proteins in vitro and its relevance to cancer.

Authors:  R Samak; R Edelstein; L Israel
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Synthesis and secretion of alpha 2-macroglobulin by human glioma established cell lines.

Authors:  R Businaro; C Fabrizi; L Fumagalli; G M Lauro
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

5.  Prognostic significance of serum alpha 1-acid glycoprotein in patients with glioblastoma multiforme: a preliminary communication.

Authors:  H Matsuura; S Nakazawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-08       Impact factor: 10.154

6.  Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes.

Authors:  A M Ward; E H Cooper; R Turner; J A Anderson; A M Neville
Journal:  Br J Cancer       Date:  1977-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.